How to Check KRM Ayurveda IPO Allotment Status

KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales. The company was incorporated on 3 September 2019.

They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country.

Hospitals and Clinics are equipped with the following infrastructure & facilities: Beds, including general wards and premium rooms, Panchakarma treatment units, Herbal pharmacy and medicine preparation unit, Ayurvedic diet kitchen, Consultation chambers for Vaidyas (Ayurvedic physicians), and In-house yoga and meditation hall.

Services include In-Patient & Out-Patient Care (Treatment for chronic diseases, lifestyle disorders, and post-operative rehabilitation), Panchakarma Therapies (Detoxification and rejuvenation programs), Specialized Clinics (Orthopedic care, skin and hair care, women's wellness, geriatric care), Wellness Packages (Stress management, weight management, preventive health plans), Medicinal Sales (Dispensary of in-house and certified Ayurvedic medicines), and Diet & Lifestyle Counseling (Personalized nutrition and yoga consultation).
As on December 31, 2025, the company have total of 443 employees operating under various departments. As of September 30, 2025, KRM Ayurveda had total assets of ₹78.12 crore.

The KRM Ayurveda IPO came with a total issue size of ₹77.49 crore, comprising entirely a fresh issue of ₹77.49 crore. The IPO opened on January 21, 2026, and closed on January 23, 2026. The allotment is expected on Tuesday, January 27, 2026. The share price band was set at ₹128 to ₹135 per share.

Don’t Miss Out on the Next Big IPO – Invest With Just a Few Clicks!

Open Account Now

Steps to Check KRM Ayurveda IPO Allotment Status on Registrar Site

• Visit the Skyline Financial Services Pvt. Ltd. 
• Select "KRM Ayurveda" from the dropdown menu on the allotment status page
• Enter your PAN ID, Demat Account Number, or Application Number in the designated field
• Complete the captcha verification process and click on the "Submit" button to view your allotment status

Steps to Check KRM Ayurveda IPO Allotment Status on BSE

• Navigate to the NSE SME IPO Allotment Status Page
• Select the issue type: equity/debt
• Choose "KRM Ayurveda" from the list of active IPOs in the dropdown menu
• Input your Application Number and PAN ID in the required fields
• Verify the captcha and click "Search" to check your allotment status

KRM Ayurveda IPO received strong investor interest, being subscribed 74.27 times overall. Below is the detailed subscription status as of 5:15:01 PM on January 23, 2026.

KRM Ayurveda IPO Subscription Status

Category-wise final subscription:
QIB Category (Ex Anchor): 63.31 times
Non-Institutional Investors (NII): 135.37 times
Retail Investors: 54.21 times

KRM Ayurveda IPO Share Price and Investment Details

The minimum investment required was ₹2,70,000 for 2 lots (2,000 shares). The issue raised ₹20.82 crore from anchor investors. Given the strong overall subscription of 74.27 times, supported by robust institutional, exceptional NII, and strong retail participation, the IPO is expected to list at a premium.

Utilisation of IPO Proceeds

The proceeds will be utilized for capital expenditure towards construction and development of telemedicine operational facilities (₹13.67 crore), purchase of CRM software and hardware infrastructure (₹1.42 crore), human resources (₹5.44 crore), repayment/prepayment of loans (₹12.50 crore), working capital requirements (₹22.90 crore), and general corporate purposes.

Business Overview

KRM Ayurveda Limited is engaged in providing healthcare services and ayurvedic products with a PAN India presence. The company has demonstrated consistent financial performance over the reported periods.

It maintains strong financial metrics with a 67.86% ROE and a debt-equity ratio of 1.31. Key strengths include skilled Ayurvedic physicians and certified therapists ensuring treatment quality, centralized GMP-certified production of medicines ensuring purity and efficacy, and a trusted brand with a loyal and repeat customer base. Investors should note the post-issue P/E ratio of 23.73 and Price to Book Value of 5.27.